Globus Medical Inc. (NYSE:GMED), a leading medical device company specializing in musculoskeletal disorders, has been making waves in the healthcare sector with its recent acquisition of Nevro Corp ...

StockNews.com upgraded shares of Globus Medical (NYSE:GMED – Free Report) from a hold rating to a buy rating in a research ...

Globus Medical started 2025 on a solid note, but a deal for loss-making Nevro creates some discomfort among investors. Read ...

Globus Medical, Inc. has a 1-year low of $49.33 and a 1-year high of $94.93. The company’s fifty day simple moving average is $86.65 and its 200-day simple moving average is $78.56. Wall Street ...

There has been an “extraordinary” increase in abuse directed towards GPs and healthcare employees, according to NHS England’s primary care medical director. Claire Fuller suggested that this rise in ...

Should You Invest in Globus Medical, Inc. (GMED)? Before you invest in Globus Medical, Inc. (GMED), want to know the best stocks to buy for the next 30 days? Check out Zacks Investment Research ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Globus Medical (GMED) reports results for the quarter ended December 2024. While this widely-known consensus ...

Globus Medical will acquire Nevro in an all-cash transaction. Both company boards of directors have unanimously approved the ...

Wall Street analysts expect Globus Medical (GMED) to post quarterly earnings of $0.76 per share in its upcoming report, which indicates a year-over-year increase of 26.7%. Revenues are expected to be ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...